Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States Medicare Beneficiaries

Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years

(2010) Hagop Kantarjian et al.   CANCER

Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders

(2009) Thomas E. Delea et al.   CURRENT MEDICAL RESEARCH AND OPINION

Outcome of patients with myelodysplastic syndromes in the Veterans Administration population

(2009) Rami S. Komrokji et al.   LEUKEMIA RESEARCH

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

(2008) M. A. Sanz et al.   BLOOD

Myelodysplastic syndromes

(2008) S. D. Nimer   BLOOD

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

(2008) D. E. Rollison et al.   BLOOD

Characteristics of US Patients with Myelodysplastic Syndromes: Results of Six Cross-sectional Physician Surveys

(2008) Mikkael A. Sekeres et al.   JNCI-Journal of the National Cancer Institute

Epidemiology of Myelodysplastic Syndromes

(2008) Sara S. Strom et al.   SEMINARS IN HEMATOLOGY